Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes
REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a…
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
April 06, 2026 10:53 ET | Source: Celldex Therapeutics, Inc. HAMPTON, N.J.,…
SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
March 17, 2026 22:46 ET | Source: SAB Biotherapeutics, Inc. MIAMI, March…
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
March 17, 2026 22:46 ET | Source: CytomX Therapeutics Inc. SOUTH SAN…
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock
February 12, 2026 21:18 ET | Source: Coherus Oncology, Inc. REDWOOD CITY,…
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M
January 23, 2026 17:00 ET | Source: Corvus Pharmaceuticals, Inc. SOUTH SAN…
Cycurion, Inc. (NASDAQ: CYCU) Announces Corrected Dividend Distribution Ratio of 0.0080 in Connection with its Previously Announced $500,000 Common Share Dividend
MCLEAN, Va., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU)…
Symbotic Announces Pricing of Primary and Secondary Offering of Class A Common Stock
December 04, 2025 22:05 ET | Source: Symbotic Inc. WILMINGTON, Mass., Dec.…
Pasithea TherapeuticsAnnounces Pricing of $60 Million Public Offering of Common Stock
Extends cash runway through at least the first half of 2028Led by…
Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
$4.25 million upfront with up to an additional $4.1 million of potential…
